Basic Information
| RNALocate ID: | RLID:11003018 |
| RNA Symbol: | hsa-miR-497-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-497 |
| RNA ID: | miRBase:MIMAT0002820 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23771658 |
| Tissue/Cell Line: | Hepatoma cells |
| Method: | Microarray|qRT-PCR |
| Description: | In line with the difference in number of detectable miRNAs, the expression levels of these miRNAs also varied between MVs and cells. Statistical analysis of the 148 co-expressing miRNAs showed that 25 miRNAs were aberrantly elevated inMVs and 75 miRNAs were significantly elevated in cells with more than two folds change. Forty-eight miRNAs had the similar signal intensity in both groups (table 1). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002346 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002347 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002348 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003013 | Exosome | Brain tissue | 23382797 |
| RLID:11003014 | Exosome | Plasma | 23663360 |
| RLID:11003015 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11003016 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003017 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000155 | Exosome | Mast cells | |
| RLID-D:11000487 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-497-5p | Diffuse large b cell lymphoma | MNDR-E-MI-54882 |
| MNDR | hsa-miR-497-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-54883 |
| MNDR | hsa-miR-497-5p | Oral squamous cell carcinoma | MNDR-E-MI-54884 |
| MNDR | hsa-miR-497-5p | Large cell neuroendocrine cancer | MNDR-E-MI-54885 |
| MNDR | hsa-miR-497-5p | Medulloblastoma | MNDR-E-MI-54886 |
| MNDR | hsa-miR-497-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54887 |
| MNDR | hsa-miR-497-5p | Lymphoma | MNDR-E-MI-54888 |
| MNDR | hsa-miR-497-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-54889 |
| MNDR | hsa-miR-497-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-54890 |
| MNDR | hsa-miR-497-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54891 |
| MNDR | hsa-miR-497-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-54892 |
| MNDR | hsa-miR-497-5p | Her2-receptor positive breast cancer | MNDR-E-MI-54893 |
| MNDR | hsa-miR-497-5p | Breast cancer luminal | MNDR-E-MI-54894 |
| MNDR | hsa-miR-497-5p | Prostate cancer | MNDR-E-MI-54895 |
| MNDR | hsa-miR-497-5p | Gastric cancer | MNDR-E-MI-54896 |
| MNDR | hsa-miR-497-5p | Alzheimer disease | MNDR-E-MI-54897 |
| MNDR | hsa-miR-497-5p | Intracranial aneurysm | MNDR-E-MI-54898 |
| MNDR | hsa-miR-497-5p | Bladder cancer | MNDR-E-MI-54899 |
| MNDR | hsa-miR-497-5p | Esophageal carcinoma | MNDR-E-MI-54900 |
| MNDR | hsa-miR-497-5p | Sarcoma | MNDR-E-MI-54901 |
| MNDR | hsa-miR-497-5p | Seizures | MNDR-E-MI-54902 |
| MNDR | hsa-miR-497-5p | Head and neck cancer | MNDR-E-MI-54903 |
| MNDR | hsa-miR-497-5p | Cardiovascular disease | MNDR-E-MI-54904 |
| MNDR | hsa-miR-497-5p | Lung cancer | MNDR-E-MI-54905 |
| MNDR | hsa-miR-497-5p | Parkinson disease | MNDR-E-MI-54906 |
| MNDR | hsa-miR-497-5p | Basal-like breast cancer | MNDR-E-MI-54907 |
| MNDR | hsa-miR-497-5p | Neuroendocrine neoplasia | MNDR-E-MI-54908 |
| MNDR | hsa-miR-497-5p | Thyroid cancer | MNDR-E-MI-54909 |
| MNDR | hsa-miR-497-5p | Pituitary neoplasms | MNDR-E-MI-54910 |
| MNDR | hsa-miR-497-5p | Pancreatic cancer | MNDR-E-MI-54911 |
| MNDR | hsa-miR-497-5p | Malignant melanoma | MNDR-E-MI-54912 |
| MNDR | hsa-miR-497-5p | Rectum adenocarcinoma | MNDR-E-MI-54913 |
| MNDR | hsa-miR-497-5p | Nephroblastoma | MNDR-E-MI-54914 |
| MNDR | hsa-miR-497-5p | Colon cancer | MNDR-E-MI-54915 |
| MNDR | hsa-miR-497-5p | Colon adenocarcinoma | MNDR-E-MI-54916 |
| MNDR | hsa-miR-497-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-54917 |
| MNDR | hsa-miR-497-5p | Familial ovarian cancer | MNDR-E-MI-54918 |
| MNDR | hsa-miR-497-5p | Carcinoma ductal breast | MNDR-E-MI-54919 |
| MNDR | hsa-miR-497-5p | Invasive ductal carcinoma | MNDR-E-MI-54920 |
| MNDR | hsa-miR-497-5p | Glioblastoma | MNDR-E-MI-54921 |
| MNDR | hsa-miR-497-5p | Astrocytoma | MNDR-E-MI-54922 |
| MNDR | hsa-miR-497-5p | Glioma | MNDR-E-MI-54923 |
| MNDR | hsa-miR-497-5p | Chordoma | MNDR-E-MI-54924 |
| MNDR | hsa-miR-497-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-54925 |
| MNDR | hsa-miR-497-5p | Temporal lobe epilepsy | MNDR-E-MI-54926 |
| MNDR | hsa-miR-497-5p | Osteosarcoma | MNDR-E-MI-54927 |
| MNDR | hsa-miR-497-5p | Breast carcinoma | MNDR-E-MI-54928 |
| MNDR | hsa-miR-497-5p | Meningioma | MNDR-E-MI-54929 |
| MNDR | hsa-miR-497-5p | Gastric adenocarcinoma | MNDR-E-MI-54930 |
| MNDR | hsa-miR-497-5p | Cervical squamous cell carcinoma | MNDR-E-MI-54931 |
| MNDR | hsa-miR-497-5p | Pituitary adenoma | MNDR-E-MI-54932 |
| MNDR | hsa-miR-497-5p | Lung squamous cell carcinoma | MNDR-E-MI-54933 |
| MNDR | hsa-miR-497-5p | Lung adenocarcinoma | MNDR-E-MI-54934 |
| MNDR | hsa-miR-497-5p | Adrenocortical cancer | MNDR-E-MI-54935 |
| MNDR | hsa-miR-497-5p | Thyroid carcinoma | MNDR-E-MI-54936 |
| MNDR | hsa-miR-497-5p | Bladder urothelial carcinoma | MNDR-E-MI-54937 |
| MNDR | hsa-miR-497-5p | Pancreatic adenocarcinoma | MNDR-E-MI-54938 |
| MNDR | hsa-miR-497-5p | Cervical cancer | MNDR-E-MI-54939 |
| MNDR | hsa-miR-497-5p | Carcinoma renal cell | MNDR-E-MI-54940 |
| MNDR | hsa-miR-497-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54941 |
| MNDR | hsa-miR-497-5p | Clear cell renal cell carcinoma | MNDR-E-MI-54942 |
| MNDR | hsa-miR-497-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-54943 |
| MNDR | hsa-miR-497-5p | Large cell carcinoma | MNDR-E-MI-54944 |
| MNDR | hsa-miR-497-5p | Cholangiocarcinoma | MNDR-E-MI-54945 |
| MNDR | hsa-miR-497-5p | Esophageal cancer | MNDR-E-MI-54946 |
| MNDR | hsa-miR-497-5p | Lung small cell carcinoma | MNDR-E-MI-54947 |
| MNDR | hsa-miR-497-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-54948 |
| MNDR | hsa-miR-497-5p | Testicular germ cell cancer | MNDR-E-MI-54949 |
| MNDR | hsa-miR-497-5p | Breast invasive carcinoma | MNDR-E-MI-54950 |
| MNDR | hsa-miR-497-5p | Hepatocellular carcinoma | MNDR-E-MI-54951 |
| MNDR | hsa-miR-497-5p | Embryonal cancer | MNDR-E-MI-54952 |
| MNDR | hsa-miR-497-5p | Familiar ovarian carcinoma | MNDR-E-MI-54953 |
| MNDR | hsa-miR-497-5p | Rheumatoid arthritis | MNDR-E-MI-54954 |
| MNDR | hsa-miR-497-5p | Barrett's adenocarcinoma | MNDR-E-MI-54955 |
| MNDR | hsa-miR-497-5p | Hodgkin lymphoma | MNDR-E-MI-54956 |
| MNDR | hsa-miR-497-5p | Burkitt lymphoma | MNDR-E-MI-54957 |
| MNDR | hsa-miR-497-5p | Colorectal cancer | MNDR-E-MI-54958 |
| MNDR | hsa-miR-497-5p | Uterine cervical neoplasms | MNDR-E-MI-54959 |
| MNDR | hsa-miR-497-5p | Nasopharyngeal cancer | MNDR-E-MI-54960 |
| MNDR | hsa-miR-497-5p | Aids dementia complex | MNDR-E-MI-54961 |
| MNDR | hsa-miR-497-5p | Pancreatitis chronic | MNDR-E-MI-54962 |
| MNDR | hsa-miR-497-5p | Barrett's carcinogenesis | MNDR-E-MI-54963 |
| MNDR | hsa-miR-497-5p | Breast cancer her3+ negative | MNDR-E-MI-54964 |
| MNDR | hsa-miR-497-5p | Duke A | MNDR-E-MI-54965 |
| MNDR | hsa-miR-497-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-54966 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO4 | Homo sapiens | RR00056018 |
TOP